Recent Advances in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms

Prediction and management of drug reaction with eosinophilia and systemic symptoms (DRESS)

(2017) Tetsuo Shiohara et al.   Expert Opinion on Drug Metabolism & Toxicology

A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome

(2017) Hideaki Watanabe et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13

(2017) Therdpong Tempark et al.   Pharmacogenetics and Genomics

Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms

(2016) A. Takehara et al.   BRITISH JOURNAL OF DERMATOLOGY

Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions

(2016) Patricia T Illing et al.   CURRENT OPINION IN IMMUNOLOGY

Severe cutaneous adverse drug reactions

(2016) Wen-Hung Chung et al.   JOURNAL OF DERMATOLOGY

Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions - a prospective comparative study

(2015) Y.-C. Chen et al.   ALLERGY

Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study

(2015) N. Ortonne et al.   BRITISH JOURNAL OF DERMATOLOGY

Elevated serum thymus and activation-regulated chemokine (TARC/CCL17) relates to reactivation of human herpesvirus 6 in drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS)

(2014) K. Ogawa et al.   BRITISH JOURNAL OF DERMATOLOGY

The serum level of HMGB1 (high mobility group box 1 protein) is preferentially high in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms

(2014) H. Fujita et al.   BRITISH JOURNAL OF DERMATOLOGY

TNF-α as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS)

(2014) Hirokazu Uno et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Skin recruitment of monomyeloid precursors involves human herpesvirus-6 reactivation in drug allergy

(2013) H. Hashizume et al.   ALLERGY

Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study

(2013) S.H. Kardaun et al.   BRITISH JOURNAL OF DERMATOLOGY

Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS)

(2013) M.-H. Chi et al.   BRITISH JOURNAL OF DERMATOLOGY

T-Cells from HLA-B*57:01+ Human Subjects Are Activated with Abacavir through Two Independent Pathways and Induce Cell Death by Multiple Mechanisms

(2013) Catherine C. Bell et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Occupational trichloroethylene hypersensitivity syndrome: Human herpesvirus 6 reactivation and rash phenotypes

(2013) Michihiro Kamijima et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Association between HLA-B*1301 and Dapsone-Induced Hypersensitivity Reactions among Leprosy Patients in China

(2013) Hongsheng Wang et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

HLA-B*13:01 and the Dapsone Hypersensitivity Syndrome

(2013) F.-R. Zhang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Six-year Retrospective Review of Drug Reaction with Eosinophilia and Systemic Symptoms

(2012) P Wongkitisophon et al.   ACTA DERMATO-VENEREOLOGICA

Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases

(2012) S. Walsh et al.   BRITISH JOURNAL OF DERMATOLOGY

Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS)

(2012) Kohei Ogawa et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Immune self-reactivity triggered by drug-modified HLA-peptide repertoire

(2012) Patricia T. Illing et al.   NATURE

Macrophages from patients with atopic dermatitis show a reduced CXCL10 expression in response to staphylococcal α-toxin

(2011) S. Kasraie et al.   ALLERGY

High-Mobility Group Box 1 Protein (HMGB1) as a Novel Diagnostic Tool for Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome

(2011) Saeko Nakajima   ARCHIVES OF DERMATOLOGY

Hypersensitivity syndrome due to trichloroethylene exposure: A severe generalized skin reaction resembling drug-induced hypersensitivity syndrome

(2011) Hideaki WATANABE   JOURNAL OF DERMATOLOGY

HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans

(2011) Mark McCormack et al.   NEW ENGLAND JOURNAL OF MEDICINE

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

Delayed drug hypersensitivity: models of T-cell stimulation

(2010) Jacqueline Adam et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

(2010) Takeshi Ozeki et al.   HUMAN MOLECULAR GENETICS

Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome

(2010) Kazunari Sugita et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Retrospective analysis of drug-induced hypersensitivity syndrome: A study of 27 patients

(2010) Chia-Chun Ang et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection

(2008) Takashi Ichiyama et al.   BRAIN & DEVELOPMENT

Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation recipients

(2008) Ayano Fujita et al.   JOURNAL OF INFECTION